AKT1 and hepatocellular carcinoma: In vivo, overexpression of an activated form of Akt by hydrodynamic tail vein injection induced HCC accompanied by enhanced de novo lipogenesis in mice [36], and genetic ablation of FASN completely suppressed Akt-driven HCC development through the inhibition of Rictor/mTORC2 signaling [38].